BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 27356035)

  • 1. Therapeutic approaches in clear cell and non-clear cell renal cell carcinoma.
    Vermassen T; De Meulenaere A; Van de Walle M; Rottey S
    Acta Clin Belg; 2017 Feb; 72(1):12-18. PubMed ID: 27356035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural and clinical course of renal cell carcinoma--better prospect for the patients.
    Beisland C; Beisland HO
    Scand J Surg; 2004; 93(2):97-101. PubMed ID: 15285560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal cell carcinoma: diagnosis, staging, and surveillance.
    Ng CS; Wood CG; Silverman PM; Tannir NM; Tamboli P; Sandler CM
    AJR Am J Roentgenol; 2008 Oct; 191(4):1220-32. PubMed ID: 18806169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal cell carcinoma.
    Whang YE; Godley PA
    Curr Opin Oncol; 2003 May; 15(3):213-6. PubMed ID: 12778014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal cell cancer: a shift in approaches for treatment of advanced disease in the United States.
    Banegas MP; Harlan LC; Mann B; Yabroff KR
    J Natl Compr Canc Netw; 2014 Sep; 12(9):1271-9. PubMed ID: 25190695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromophobe renal cell carcinoma: a review of an uncommon entity.
    Vera-Badillo FE; Conde E; Duran I
    Int J Urol; 2012 Oct; 19(10):894-900. PubMed ID: 22715810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy for renal cell carcinoma.
    Bleumer I; Oosterwijk E; De Mulder P; Mulders PF
    Eur Urol; 2003 Jul; 44(1):65-75. PubMed ID: 12814677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Renal cell carcinoma in Iceland].
    Thoroddsen A; Einarsson GV; Gudbjartsson T
    Laeknabladid; 2007 Apr; 93(4):283-97. PubMed ID: 17460340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review.
    Gupta K; Miller JD; Li JZ; Russell MW; Charbonneau C
    Cancer Treat Rev; 2008 May; 34(3):193-205. PubMed ID: 18313224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NCCN practice guidelines for kidney cancer. National Comprehensive Cancer Network.
    Oncology (Williston Park); 1998 Nov; 12(11A):396-412. PubMed ID: 10028523
    [No Abstract]   [Full Text] [Related]  

  • 11. Integration of surgery and systemic therapy for renal cell carcinoma.
    Kenney PA; Wood CG
    Urol Clin North Am; 2012 May; 39(2):211-31, vii. PubMed ID: 22487764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy.
    Lam JS; Shvarts O; Leppert JT; Figlin RA; Belldegrun AS
    J Urol; 2005 Jun; 173(6):1853-62. PubMed ID: 15879764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histology.
    Motzer RJ; Bacik J; Mariani T; Russo P; Mazumdar M; Reuter V
    J Clin Oncol; 2002 May; 20(9):2376-81. PubMed ID: 11981011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel immunotherapeutic strategies in development for renal cell carcinoma.
    Inman BA; Harrison MR; George DJ
    Eur Urol; 2013 May; 63(5):881-9. PubMed ID: 23084331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Escudier B; Porta C; Schmidinger M; Rioux-Leclercq N; Bex A; Khoo V; Gruenvald V; Horwich A;
    Ann Oncol; 2016 Sep; 27(suppl 5):v58-v68. PubMed ID: 27664262
    [No Abstract]   [Full Text] [Related]  

  • 16. Current management of advanced and metastatic renal cell carcinoma.
    Ather MH; Masood N; Siddiqui T
    Urol J; 2010; 7(1):1-9. PubMed ID: 20209445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical management of large renal tumors.
    Wszolek MF; Wotkowicz C; Libertino JA
    Nat Clin Pract Urol; 2008 Jan; 5(1):35-46. PubMed ID: 18185512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NCCN GuidelinesĀ® Insights: Kidney Cancer, Version 2.2024.
    Motzer RJ; Jonasch E; Agarwal N; Alva A; Bagshaw H; Baine M; Beckermann K; Carlo MI; Choueiri TK; Costello BA; Derweesh IH; Desai A; Ged Y; George S; Gore JL; Gunn A; Haas N; Johnson M; Kapur P; King J; Kyriakopoulos C; Lam ET; Lara PN; Lau C; Lewis B; Madoff DC; Manley B; Michaelson MD; Mortazavi A; Ponsky L; Ramalingam S; Shuch B; Smith ZL; Sosman J; Sweis R; Zibelman M; Schonfeld R; Stein M; Gurski LA
    J Natl Compr Canc Netw; 2024 Feb; 22(1):4-16. PubMed ID: 38394781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating innovative therapeutic strategies into the management of renal cell carcinoma.
    Dutcher JP; Mourad WF; Ennis RD
    Oncology (Williston Park); 2012 Jun; 26(6):526-30, 532, 534. PubMed ID: 22870536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal cell cancer: overview of the current therapeutic landscape.
    Erman M; Benekli M; Basaran M; Bavbek S; Buyukberber S; Coskun U; Demir G; Karabulut B; Oksuzoglu B; Ozkan M; Sevinc A; Yalcin S
    Expert Rev Anticancer Ther; 2016 Sep; 16(9):955-68. PubMed ID: 27548347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.